Plain-English translation of NCT06056271 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Atrial Fibrillation research guide →This is a real-world registry study that tracks outcomes in patients who have had ablation surgery for atrial fibrillation using Volta Medical's VX1 or AF-Xplorer AI-guided mapping systems. Instead of testing a new medication, researchers are observing how these mapping tools perform during actual surgical procedures in hospitals across the United States. The goal is to understand whether the new technology helps doctors achieve better results and improves patients' long-term health.
Atrial fibrillation is a common heart rhythm problem that can lead to serious complications, and ablation surgery is an established treatment. This study exists to see how new AI-guided mapping technology performs in everyday clinical practice—whether it helps doctors map the heart more accurately, reduces repeat procedures, and improves patient outcomes in the real world.
You likely qualify if…
You likely don't qualify if…
As a participant, you would allow researchers to collect and review your medical information related to your ablation procedure and follow-up care—including procedure details, complications, and long-term heart rhythm outcomes. You will need to provide written consent and may be asked to complete follow-up visits or surveys to track how you're doing after surgery. The study does not involve taking new medications; instead, it simply observes your clinical progress using the new mapping technology your doctor already used during your procedure.
AI-generated summary from trial data · Aug 6, 2026 · Not medical advice
United States